Disease | leukemia, acute myeloid |
Comorbidity | C0026946|fungal disease |
Sentences | 5 |
PubMedID- 22471310 | Treatment cost of invasive fungal disease (ifd) in patients with acute myelogenous leukaemia (aml) or myelodysplastic syndrome (mds) in german hospitals. |
PubMedID- 24644249 | In preventing invasive fungal disease (ifd) in patients with acute myelogenous leukemia (aml) or myelodysplastic syndrome (mds), clinical trials demonstrated efficacy of posaconazole over fluconazole and itraconazole. |
PubMedID- 26366612 | Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an asian teaching hospital. |
PubMedID- 20202112 | Classification of invasive fungal disease in patients with acute myeloid leukaemia. |
PubMedID- 22102706 | Background: posaconazole is effective as primary antifungal prophylaxis of invasive fungal diseases in patients with acute myeloid leukemia. |
Page: 1